Ensayo de fase III, aleatorizado, multicéntrico y abierto de lapatinib, trastuzumab y su combinación más paclitaxel como neoadyuvantes en mujeres con cáncer de mama primario HER2 positivo
José Baselga, MD, PhD (Memorial Sloan Kettering Cancer Center)
Holger Eidtmann, MD (University Medical Center Schleswig-Holstein Campus Kiel)
| Cookie | Duración | Descripción |
|---|---|---|
| _hjIncludedInSessionSample_2433519 | 2 minutes | Description is currently not available. |
| FormsWebSessionId | 1 month | Description is currently not available. |
| m | 1 year 1 month 4 days | No description available. |
| MC1 | 1 year | No description available. |
| RpsAuthNonce | 1 month | Description is currently not available. |
| VISITOR_PRIVACY_METADATA | 5 months 27 days | Description is currently not available. |
| Cookie | Duración | Descripción |
|---|---|---|
| _hjAbsoluteSessionInProgress | 30 minutes | Hotjar sets this cookie to detect a user's first pageview session, which is a True/False flag set by the cookie. |